Article | May 11, 2022

Ultra-Rare Disease And Clinical Research– Different Approaches For Unique Studies

Source: THREAD
GettyImages-1341484868 rare disease

In a previous blog, we discussed ultra-rare diseases and the unique research challenges they pose to the development of new therapies. The nature of rare and ultra-rare disease means that drug development pathways and the types of studies commonly conducted can differ from the pathways and approaches used for more common diseases.

In this piece, we will discuss some of the approaches commonly taken to bring new ultra-rare disease therapies to market, and how decentralized clinical trial (DCT) elements help.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader